benzoxazoles has been researched along with cx 5461 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, B; Huang, L; Li, H; Liang, Y; Liao, G; Luo, H; Shi, S; Wang, L; Wang, Z; Xia, J; Xu, B | 1 |
1 other study(ies) available for benzoxazoles and cx 5461
Article | Year |
---|---|
Combined inhibition of RNA polymerase I and mTORC1/2 synergize to combat oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzothiazoles; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; DNA End-Joining Repair; DNA, Ribosomal; Drug Synergism; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Naphthyridines; Protein Kinase Inhibitors; Pyrimidines; Reactive Oxygen Species; RNA Polymerase I; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2021 |